Alexza Molecular Delivery Corp. privately raised $52 million to thicken its clinical pipeline. (BioWorld Today)

In rapid succession, Infinity Pharmaceuticals Inc. announced its second and third collaborations, forming with two pharmaceutical companies agreements that include equity investments. (BioWorld Today)

In rapid succession, Infinity Pharmaceuticals Inc. announced its second and third collaborations, forming with two pharmaceutical companies agreements that include equity investments. (BioWorld Today)